Medicinal Products

Infanrix Hexa

Name Infanrix Hexa
Active Substance diphtheria toxoid / tetanus toxoid / Bordetella pertussis antigens (pertussis toxoid, filamentous haemagglutinin, pertactin) / hepatitis B surface antigen / poliovirus (inactivated) (type 1 (Mahoney strain), type 2 (MEF-1 strain), type 3 (Saukett strain)) / Haemophilus influenzae type b polysaccharide
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
ATC Code J07CA09
Medicinal product marketed in the Croatia Da

Note

The medicinal product has been authorised via centralised procedure in all Member States of the European Union based on the European Medicines Agency's expert opinion. Additional information on the medicinal product can be found under the following link:https://www.ema.europa.eu/en/medicines/human/EPAR/infanrix-hexa

The marketing authorisation has been granted by the European Commission. All marketing authorisations of the European Commission can be found under the following link: http://ec.europa.eu/health/documents/community-register/html/index_en.htm

Direct Healthcare Professional Communication

Name Date Download
Pismo zdravstvenim radnicima o istjecanju cjepiva iz štrcaljki nekoliko različitih cjepiva nositelja odobrenja GlaxoSmithKline Biologicals 04.04.2018 GlaxoSmithKline d.o.o.
Back